A person’s microbiome may be linked to the risk of developing long-haul COVID-19 syndrome after infection with SARS-CoV-2.
— Read on www.clinicaladvisor.com/home/topics/gastroenterology-information-center/long-haul-covid-19-linked-altered-microbiome/

“…up to 75% of patients hospitalized with COVID-19 described at least 1 symptom 6 months after discharge. These included respiratory, neuropsychiatric (headache, dizziness, loss of taste and smell, anxiety, poor concentration, disrupted sleep, low mood, poor memory, blurred vision), gastrointestinal, hair loss, and musculoskeletal symptoms as well as fatigue.”